CKOCF yields 3.08% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CKOCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CKOCF + PFE for your $10,000?
Chudenko Corporation operates as an equipment engineering company in Japan. It undertakes electrical works, such as light/outlet, image/sound/TV/broadcast, power receiving/transforming, and plant equipment works; energy-related works comprising wind/solar power generation, cogeneration, energy-saving power, and private power generation system works; and environment-related works, including recycling and heat storage system works. The company also undertakes electric line/distribution line/leading wire/underground line works; and office/household water and sewerage, and industrial water and sewerage facilities works, as well as constructs, maintains, and repairs roads and architecture. In addition, it is involved in the Internet/Intranet, CATV/community wireless system/telephone, LAN, optical and mobile communication, and OA floor equipment, as well as system integration and integrated information wiring works; air-conditioning/cooling, heating/water supply, drainage/sanitation/environment equipment, and clean room system works; and fire-alarm, theft monitoring/alarm, and firefighting/evacuation guidance equipment works. Further, the company engages in building equipment renewal and housing renovation works, as well as pylon works; designs, produces, sells, repairs, installs, and maintains electrical equipment, such as distribution boards, supervisory panels, control boards, power source equipment, communication devices, heavy current devices, various measuring devices, and others; and plans, develops, sells, rents, operates, and maintains software and information processing systems. Additionally, it provides consulting and maintenance services consisting of energy saving diagnosis/support services, as well as disaster prevention and firefighting equipment inspection services. The company was founded in 1944 and is headquartered in Hiroshima, Japan.
Full CKOCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.